TickerFactsScreenerDevelopers

Revolution Medicines, Inc. (RVMD) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: $1.21M2019: -$49.62M2020: -$100.06M2021: -$147.18M2022: -$224.40M2023: -$350.57M2024: -$557.44M2025: -$897.74M-$897.74M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$897.74M-61.0%
2024-$557.44M-59.0%
2023-$350.57M-56.2%
2022-$224.40M-52.5%
2021-$147.18M-47.1%
2020-$100.06M-101.7%
2019-$49.62M-4190.4%
2018$1.21M—